# Spero Therapeutics, Inc.: Form 8-K, filed Feb 9, 2024

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K
- Filed: 2024-02-09
- Accepted by EDGAR: Feb 9, 2024, 16:05 ET
- Period: 2024-02-05
- Accession: 0001193125-24-029913
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312524029913/d45988d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312524029913/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312524029913/d45988d8k.htm

Filed Feb 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-029913. Last ingested by Listed: Nov 11, 2026, 04:12 ET. No prices; not investment advice.